Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19
Abstract SARS-CoV-2 infection has a risk to develop into life-threatening COVID-19 disease. Whereas age, hypertension, and chronic inflammatory conditions are risk factors, underlying host factors and markers for disease severity, e.g. requiring intensive care unit (ICU) treatment, remain poorly def...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/122d14a3063c481cb0cc3d33b02d79ac |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:122d14a3063c481cb0cc3d33b02d79ac |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:122d14a3063c481cb0cc3d33b02d79ac2021-12-02T15:09:57ZLongitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-1910.1038/s41598-020-77525-w2045-2322https://doaj.org/article/122d14a3063c481cb0cc3d33b02d79ac2020-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-77525-whttps://doaj.org/toc/2045-2322Abstract SARS-CoV-2 infection has a risk to develop into life-threatening COVID-19 disease. Whereas age, hypertension, and chronic inflammatory conditions are risk factors, underlying host factors and markers for disease severity, e.g. requiring intensive care unit (ICU) treatment, remain poorly defined. To this end, we longitudinally profiled blood inflammation markers, antibodies, and 101 plasma proteins of hospitalized COVID-19 patients who did or did not require ICU admission. While essentially all patients displayed SARS-CoV-2-specific antibodies and virus-neutralization capacity within 12–15 days, a rapid, mostly transient upregulation of selective inflammatory markers including IL-6, CXCL10, CXCL11, IFNγ, IL-10, and monocyte-attracting CCL2, CCL7 and CCL8, was particularly evident in ICU patients. In addition, there was consistent and sustained upregulation of apoptosis-associated proteins CASP8, TNFSF14, HGF, and TGFB1, with HGF discriminating between ICU and non-ICU cohorts. Thus, COVID-19 is associated with a selective inflammatory milieu within which the apoptotic pathway is a cardinal feature with potential to aid risk-based patient stratification.Liis HaljasmägiAhto SalumetsAnna Pauliina RummMeeri JürgensonEkaterina KrassohhinaAnu RemmHanna SeinLauri KareinenOlli VapalahtiTarja SironenHedi PetersonLili MilaniAnu TammAdrian HaydayKai KisandPärt PetersonNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-12 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Liis Haljasmägi Ahto Salumets Anna Pauliina Rumm Meeri Jürgenson Ekaterina Krassohhina Anu Remm Hanna Sein Lauri Kareinen Olli Vapalahti Tarja Sironen Hedi Peterson Lili Milani Anu Tamm Adrian Hayday Kai Kisand Pärt Peterson Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19 |
description |
Abstract SARS-CoV-2 infection has a risk to develop into life-threatening COVID-19 disease. Whereas age, hypertension, and chronic inflammatory conditions are risk factors, underlying host factors and markers for disease severity, e.g. requiring intensive care unit (ICU) treatment, remain poorly defined. To this end, we longitudinally profiled blood inflammation markers, antibodies, and 101 plasma proteins of hospitalized COVID-19 patients who did or did not require ICU admission. While essentially all patients displayed SARS-CoV-2-specific antibodies and virus-neutralization capacity within 12–15 days, a rapid, mostly transient upregulation of selective inflammatory markers including IL-6, CXCL10, CXCL11, IFNγ, IL-10, and monocyte-attracting CCL2, CCL7 and CCL8, was particularly evident in ICU patients. In addition, there was consistent and sustained upregulation of apoptosis-associated proteins CASP8, TNFSF14, HGF, and TGFB1, with HGF discriminating between ICU and non-ICU cohorts. Thus, COVID-19 is associated with a selective inflammatory milieu within which the apoptotic pathway is a cardinal feature with potential to aid risk-based patient stratification. |
format |
article |
author |
Liis Haljasmägi Ahto Salumets Anna Pauliina Rumm Meeri Jürgenson Ekaterina Krassohhina Anu Remm Hanna Sein Lauri Kareinen Olli Vapalahti Tarja Sironen Hedi Peterson Lili Milani Anu Tamm Adrian Hayday Kai Kisand Pärt Peterson |
author_facet |
Liis Haljasmägi Ahto Salumets Anna Pauliina Rumm Meeri Jürgenson Ekaterina Krassohhina Anu Remm Hanna Sein Lauri Kareinen Olli Vapalahti Tarja Sironen Hedi Peterson Lili Milani Anu Tamm Adrian Hayday Kai Kisand Pärt Peterson |
author_sort |
Liis Haljasmägi |
title |
Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19 |
title_short |
Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19 |
title_full |
Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19 |
title_fullStr |
Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19 |
title_full_unstemmed |
Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19 |
title_sort |
longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe covid-19 |
publisher |
Nature Portfolio |
publishDate |
2020 |
url |
https://doaj.org/article/122d14a3063c481cb0cc3d33b02d79ac |
work_keys_str_mv |
AT liishaljasmagi longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19 AT ahtosalumets longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19 AT annapauliinarumm longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19 AT meerijurgenson longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19 AT ekaterinakrassohhina longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19 AT anuremm longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19 AT hannasein longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19 AT laurikareinen longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19 AT ollivapalahti longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19 AT tarjasironen longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19 AT hedipeterson longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19 AT lilimilani longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19 AT anutamm longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19 AT adrianhayday longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19 AT kaikisand longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19 AT partpeterson longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19 |
_version_ |
1718387735139450880 |